|Day Low/High||34.45 / 35.10|
|52 Wk Low/High||25.06 / 40.64|
The most recent short interest data has been released for the 07/29/2016 settlement date, which shows a 314,564 share decrease in total short interest for Omnicell Inc , to 1,243,238, a decrease of 20.19% since 07/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Solutions to Advance Collaboration and Standardization Between Five Facilities in Recently Established Health System
Enhanced Collaboration Between Pharmacy and Nursing Departments Helps Streamline Medication Management and Enhance Patient Care
Stocks with insider trader activity include XPLR, ACET and OMCL
Four small-cap growth companies look like they're on sale now.
New Automated Solutions are Interoperable with the Health System's Electronic Medical Record for Streamlined Medication Management
Legacy Aesynt Products, Now Part of Omnicell, Enhance Drug Distribution and Safety for Patients and Employees
Increasing the Accuracy of Hand Packing for Pharmacists Helps Scale Adherence Programs
New Divisional Presidents Provide Strong Leadership and Experience to Drive Growth Strategy
Find-A-Pharmacy Online Tool Simplifies Patient Access to Pharmacies Offering SureMed Solutions
Suite of Omnicell Solutions and Customer Presentations Showcase Tools to Optimize Medication Management from Hospital to Home
Omnicell Interoperability with the Health System's Electronic Health Record Expected to Further Streamline Medication Management
System will be showcased at Arab Health Congress in Dubai January 25-28
- Creates the broadest product portfolio in the industry, providing customers with an unprecedented choice of technology in medication management systems
Stocks with insider trader activity include SON, GES and OMCL
Expiration of the HSR Waiting Period Satisfies one of the Conditions to Close for Aesynt Acquisition
Since this summer's market low, small-cap stocks have been outperforming large-cap stocks. Here are small caps with 'persistently strong top-line growth and improving fundamentals,' according to RBC Capital Markets.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ALB, CUB, DLTR, FRO, GIG, HWBK, KZ, OFS, OMCL, RGS, TEDU Downgrades: ARC, ENTA, NX, SDRL Initiations: MELR Read on to get TheStreet Quant Ratings' detailed report:
Aesynt LTM 9/30/15 revenue and adjusted EBITDA at $190 million and $23 million, respectively, up from $182 million and $20 million for LTM 6/30/15
For the Third Year in a Row Omnicell Also Honored as the #1 Overall Pharmacy Automation Equipment Vendor
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BOCH, HHC, HMIN, PLCM, PRIM, QLYS, RUBI, SFST, SPTN Downgrades: CCO, CDI, DCO, DIOD, FSTR, IBM, ICON, LIOX, OMCL, QUAD, SAVE, STWD, TIME, VET, VNDA Initiations: HUBS, OMAM, OPHT, OSGB, VBTX Read on to get TheStreet Quant Ratings' detailed report:
Automation Expected to Streamline Medication Delivery at Canada's Premier Children's Hospital
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
- Offers healthcare providers unparalleled flexibility and scalability in medication management systems
Stocks with insider trader activity include CVGW, OMCL and LLY
Investors eyeing a purchase of Omnicell Inc stock, but tentative about paying the going market price of $31.41/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May 2016 put at the $30 strike, which has a bid at the time of this writing of $2.15.
SureMed's Easy-to-Follow Multimed Blister Cards Help Pharmacists Support Patient Participation in Their Own Care